Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

INTRODUCTION: Durvalumab after concurrent chemoradiation (cCRT) is now standard of care for unresected stage III non–small cell lung cancer (NSCLC). However, there is limited data on radiation pneumonitis (RP) with this regimen. Therefore, we assessed RP and evaluated previously validated toxicity m...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Shaverdian, Narek, Thor, Maria, Shepherd, Annemarie F., Offin, Michael D., Jackson, Andrew, Wu, Abraham J., Gelblum, Daphna Y., Yorke, Ellen D., Simone, Charles B., Chaft, Jamie E., Hellmann, Matthew D., Gomez, Daniel R., Rimner, Andreas, Deasy, Joseph O.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333832/
https://ncbi.nlm.nih.gov/pubmed/32372571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3113
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items